Healthcare provider profile · identity verified

Craig Alan Johnson, D.O.

Allopathic & Osteopathic Physicians|Family Medicine · BRAZIL, IN · NPI 1295725851

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Craig Alan Johnson, D.O. received $55.97 in general payments during 2025 across 3 reported records.

Daiichi Sankyo Inc. accounted for 38.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Vraylar.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Lumigan by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Vraylar by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Nuedexta by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$55.97

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Daiichi Sankyo Inc.	Unresolved — no canonical attribution shown	$21.42	38.3%	1	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$19.92	35.6%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$14.63	26.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$41.34	2
Education	$14.63	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Enhertu Normalized: enhertu	Drug	Daiichi Sankyo Inc.	$21.42	1	2025
Source payment records 2025-05-12 · Daiichi Sankyo Inc. · $21.42 · Open Payments source
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$19.92	1	2025
Source payment records 2025-06-14 · ABBVIE INC. · $19.92 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$14.63	1	2025
Source payment records 2025-02-10 · Otsuka America Pharmaceutical, Inc. · $14.63 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
VRAYLAR vraylar	2025	Vraylar	2024	28 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LUMIGAN open payments reported associated product	CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548	Lumigan · 2024 Exact normalized brand match · 1 Part D row	22	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	28	suppressed by CMS
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	NUEDEXTA open payments reported associated product	CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901	Nuedexta · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1050	161
Levothyroxine Sodium	Levothyroxine Sodium	887	108
Furosemide	Furosemide	844	147
Eliquis	Apixaban	772	90
Potassium Chloride	Potassium Chloride	694	121
Pantoprazole Sodium	Pantoprazole Sodium	619	109
Metoprolol Succinate	Metoprolol Succinate	586	92
Gabapentin	Gabapentin	559	77
Sertraline Hcl	Sertraline Hcl	488	73
Duloxetine Hcl	Duloxetine Hcl	442	63
Amlodipine Besylate	Amlodipine Besylate	423	61
Carvedilol	Carvedilol	388	52
Tamsulosin Hcl	Tamsulosin Hcl	387	57
Trazodone Hcl	Trazodone Hcl	371	54
Omeprazole	Omeprazole	362	58
Donepezil Hcl	Donepezil Hcl	350	50
Escitalopram Oxalate	Escitalopram Oxalate	326	52
Mirtazapine	Mirtazapine	307	72
Losartan Potassium	Losartan Potassium	289	41
Memantine Hcl	Memantine Hcl	288	37
Lisinopril	Lisinopril	274	50
Famotidine	Famotidine	264	37
Metoprolol Tartrate	Metoprolol Tartrate	253	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	249	76
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	239	39
Metformin Hcl	Metformin Hcl	234	37
Clopidogrel	Clopidogrel Bisulfate	229	43
Quetiapine Fumarate	Quetiapine Fumarate	228	30
Divalproex Sodium	Divalproex Sodium	224	35
Xarelto	Rivaroxaban	222	16
Carbidopa-Levodopa	Carbidopa/Levodopa	221	29
Allopurinol	Allopurinol	215	31
Torsemide	Torsemide	196	28
Jardiance	Empagliflozin	190	33
Nystatin	Nystatin	188	74
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	175	35
Fluoxetine Hcl	Fluoxetine Hcl	168	23
Levetiracetam	Levetiracetam	168	25
Spironolactone	Spironolactone	168	37
Ropinirole Hcl	Ropinirole Hcl	163	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	159	18
Baclofen	Baclofen	157	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	150	24
Olanzapine	Olanzapine	146	21
Risperidone	Risperidone	144	19
Prednisone	Prednisone	127	51
Cephalexin	Cephalexin	125	54
Pregabalin	Pregabalin	122	18
Finasteride	Finasteride	117	16
Fluticasone Propionate	Fluticasone Propionate	115	39
Buspirone Hcl	Buspirone Hcl	113	25
Lorazepam	Lorazepam	113	27
Sucralfate	Sucralfate	113	14
Albuterol Sulfate Hfa	Albuterol Sulfate	106	46
Tizanidine Hcl	Tizanidine Hcl	106	25
Insulin Lispro Kwikpen U-100	Insulin Lispro	105	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	104	61
Divalproex Sodium Er	Divalproex Sodium	103	16
Myrbetriq	Mirabegron	103	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	100	44
Hydralazine Hcl	Hydralazine Hcl	96	17
Rosuvastatin Calcium	Rosuvastatin Calcium	95	suppressed
Simvastatin	Simvastatin	88	11
Ondansetron Hcl	Ondansetron Hcl	86	59
Arexvy	Rsvpref3 Antigen/As01e/Pf	84	82
Bupropion Xl	Bupropion Hcl	84	12
Lactulose	Lactulose	83	19
Diclofenac Sodium	Diclofenac Sodium	82	19
Bumetanide	Bumetanide	81	12
Fluconazole	Fluconazole	80	49
Venlafaxine Hcl Er	Venlafaxine Hcl	80	12
Entresto	Sacubitril/Valsartan	79	suppressed
Midodrine Hcl	Midodrine Hcl	78	14
Montelukast Sodium	Montelukast Sodium	78	14
Enulose	Lactulose	76	suppressed
Loperamide	Loperamide Hcl	76	45
Humalog Kwikpen U-100	Insulin Lispro	74	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	73	42
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	67	44
Clonazepam	Clonazepam	67	12
Ezetimibe	Ezetimibe	67	11
Paroxetine Hcl	Paroxetine Hcl	67	suppressed
Tramadol Hcl	Tramadol Hcl	65	21
Lamotrigine	Lamotrigine	64	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	63	30
Valsartan	Valsartan	61	12
Nyamyc	Nystatin	59	39
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	36
Citalopram Hbr	Citalopram Hydrobromide	56	11
Vitamin D2	Ergocalciferol (Vitamin D2)	55	suppressed
Humalog	Insulin Lispro	54	16
Methenamine Hippurate	Methenamine Hippurate	54	suppressed
Metformin Hcl Er	Metformin Hcl	52	suppressed
Nystop	Nystatin	52	22
Albuterol Sulfate	Albuterol Sulfate	51	27
Alprazolam	Alprazolam	51	18
Digoxin	Digoxin	51	suppressed
Ketoconazole	Ketoconazole	51	19
Tradjenta	Linagliptin	51	suppressed
Hydrocortisone	Hydrocortisone	50	14
Latanoprost	Latanoprost	49	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	46	suppressed
Paliperidone Er	Paliperidone	46	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	45	12
Alendronate Sodium	Alendronate Sodium	43	14
Aripiprazole	Aripiprazole	43	12
Ibandronate Sodium	Ibandronate Sodium	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	14
Colesevelam Hcl	Colesevelam Hcl	39	suppressed
Glipizide Er	Glipizide	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	17
Januvia	Sitagliptin Phosphate	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	39	suppressed
Colchicine	Colchicine	38	suppressed
Ondansetron Odt	Ondansetron	38	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	12
Azelastine Hcl	Azelastine Hcl	35	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Metronidazole	Metronidazole	33	17
Azithromycin	Azithromycin	32	26
Novolog Flexpen	Insulin Aspart	32	13
Oxycodone Hcl	Oxycodone Hcl	32	13
Movantik	Naloxegol Oxalate	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	31	suppressed
Verapamil Hcl	Verapamil Hcl	31	suppressed
Admelog Solostar	Insulin Lispro	30	suppressed
Galantamine Hbr	Galantamine Hbr	30	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	30	suppressed
Topiramate	Topiramate	30	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	29	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Water	Water For Irrigation,sterile	29	suppressed
Cefdinir	Cefdinir	28	21
Oxcarbazepine	Oxcarbazepine	28	suppressed
Vraylar	Cariprazine Hcl	28	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Calcitriol	Calcitriol	26	suppressed
Aptiom	Eslicarbazepine Acetate	25	suppressed
Levofloxacin	Levofloxacin	25	14
Nitroglycerin	Nitroglycerin	25	19
Brilinta	Ticagrelor	24	suppressed
Dutasteride	Dutasteride	24	suppressed
Glucagon Emergency Kit	Glucagon	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Fentanyl	Fentanyl	22	suppressed
Lumigan	Bimatoprost	22	suppressed
Ozempic	Semaglutide	22	suppressed
Vancomycin Hcl	Vancomycin Hcl	22	suppressed
Cyclosporine	Cyclosporine	21	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	21	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Otezla	Apremilast	21	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Cefazolin Sodium	Cefazolin Sodium	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	13
Atenolol	Atenolol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Kesimpta Pen	Ofatumumab	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	17	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	17	11
Memantine Hcl Er	Memantine Hcl	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Budesonide Ec	Budesonide	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Atropine Sulfate	Atropine Sulfate	15	15
Dexamethasone	Dexamethasone	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Methylprednisolone	Methylprednisolone	14	suppressed
Restasis Multidose	Cyclosporine	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Cabergoline	Cabergoline	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	11
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Linzess	Linaclotide	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Norethindrone	Norethindrone	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Restasis	Cyclosporine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$55.97 · 3 records	Daiichi Sankyo Inc.	Enhertu, REXULTI, VRAYLAR	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Vraylar play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error